文献速递胸部肿瘤

第八版肺癌TNM分类中分期分组的验证

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer.
PubMed 文献 · J Thorac Oncol · 2017-08-04

本研究在中国两个外科中心回顾性分析2005至2012年间接受手术治疗的3599例病理分期IA至IIIA(第七版TNM)非小细胞肺癌患者,按第八版TNM重新分期。中位随访48.7个月,除IA3期与IB期外,相邻分期分组的总生存差异显著;第八版TNM的R²略高于第七版(0.172 vs 0.162)。

要点

  • 第八版TNM相邻分期分组总生存差异显著,但IA3期与IB期除外。
  • 第八版TNM的R²为0.172,第七版为0.162。
  • 研究提供了第八版TNM在中国手术NSCLC患者中的外部验证。

核心结论

  • 本研究在中国手术非小细胞肺癌患者中外部验证了第八版TNM分期分组,除IA3期与IB期外相邻分期分组总生存差异显著。

研究设计与样本

  • 回顾性分析2005至2012年中国两个外科中心接受手术治疗的3599例病理分期IA至IIIA(第七版TNM)非小细胞肺癌患者。
  • 所有患者按第八版TNM重新分类,采用log-rank检验和Cox回归模型比较相邻分期分组生存,计算R²评估两种TNM分期的区分度。

主要发现

  • 中位随访时间为48.7个月。
  • 按第八版TNM,相邻分期分组的总生存差异显著,但IA3期与IB期除外。
  • 第八版TNM的R²略高于第七版(0.172 vs 0.162)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The aim of this study was to validate stage groupings in the eighth edition of the TNM classification in an independent Chinese cohort. METHODS: We retrospectively analyzed a total of 3599 patients with pathological stage IA to IIIA (seventh edition of the TNM) NSCLC who underwent surgical treatment in two surgical centers in the People's Republic of China between 2005 and 2012. All patients were reclassified according to the eighth edition of the TNM classification. Survival was compared between adjacent stage groupings by using a log-rank test and a Cox regression model. R2 was calculated to evaluate the discrimination of the two TNM stage classifications. RESULTS: The median follow-up time was 48.7 months. According to the eighth edition of the TNM classification, the overall survival (OS) of adjacent stage groupings showed significant differences except for IA3 vs. IB. The eighth edition of the TNM classification yielded a slightly higher R2 than the seventh edition (0.172 vs. 0.162). CONCLUSIONS: This study provided an external validation of the stage groupings in the eighth edition of the TNM classification for lung cancer among surgically treated Chinese patients with NSCLC.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Sui X, Jiang W, Chen H, et al. Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2017. PMID: 28782726. doi:10.1016/j.jtho.2017.07.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。